Since the analysis of pro-inflammatory mediators suggested a potential role for CXCL1 and CXCL2 in the manifestation of CLP-induced AKI, we supplemented plasma from CLP mice with appropriate blocking antibodies right before its transfer into recipient mice. Here, CXCL1 is linked to acute kidney injury.